Effect of Evolocumab on Coronary Atherosclerosis

Clinical trial NCT03689946 · COMPLETED

Trial details

NCT number: NCT03689946
Sponsor: Cedars-Sinai Medical Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiovascular Disease Hyperlipidemia

Start date: 2019-03-19
Primary completion: 2023-01-28
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.